Health
Moderna’s Flu-Covid Combo Shot Hits Goal in Late-Stage Trial
This article is for subscribers only.
Moderna Inc. said its combination flu and Covid shot met the goals of a pivotal late-stage trial, bringing the company one step closer to a more convenient jab that could help combat vaccine fatigue.
The trial compared people who got Moderna’s combination vaccine with those who got both a competitor’s flu shot and Moderna’s Covid vaccine during the same visit. Moderna’s combination shot generated higher immune responses against the influenza virus and SARS-CoV-2 than licensed flu and Covid vaccines in adults 50 years and older, according to a statement Monday. Moderna said it will engage with regulators on the next steps for the program.